Wave Life Sciences (WVE) Current Assets (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Current Assets came in at $507.5 million in Q2 2026, up 127.02% YoY from $223.6 million in Q2 2025, and down 9.58% on a QoQ basis from $561.3 million in Q1 2026.
Wave Life Sciences (WVE) Current Assets (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Current Assets data on file, last reported at $507.5 million in Q2 2026.
- Quarterly Current Assets rose 127.02% year-over-year to $507.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $507.5 million (up 127.02% YoY) and the FY2025 annual result came in at $614.8 million, up 91.89% from the prior year.
- Current Assets fell to $507.5 million in Q2 2026, from $561.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $614.8 million in Q4 2025 to a low of $98.5 million in Q4 2022.
- A 5-year average of $261.5 million and a median of $217.5 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 39.39% — and 2023, when it surged 138.87%.
- Tracing WVE's Current Assets over 5 years: stood at $98.5 million in 2022, then surged by 138.87% to $235.4 million in 2023, then surged by 36.12% to $320.4 million in 2024, then soared by 91.89% to $614.8 million in 2025, then fell by 17.45% to $507.5 million in 2026.
- The last three Current Assets figures came in at $507.5 million (Q2 2026), $561.3 million (Q1 2026), and $614.8 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 507.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 507.51 Mn |
| Mar 31, 2026 | 561.27 Mn |
| Dec 31, 2025 | 614.81 Mn |
| Sep 30, 2025 | 215.49 Mn |
| Jun 30, 2025 | 223.56 Mn |
| Mar 31, 2025 | 257.98 Mn |
| Dec 31, 2024 | 320.39 Mn |
| Sep 30, 2024 | 324.52 Mn |
| Jun 30, 2024 | 172.08 Mn |
| Mar 31, 2024 | 196.77 Mn |
| Dec 31, 2023 | 235.37 Mn |
| Sep 30, 2023 | 158.57 Mn |
| Jun 30, 2023 | 184.71 Mn |
| Mar 31, 2023 | 219.59 Mn |
| Dec 31, 2022 | 98.54 Mn |
| Sep 30, 2022 | 131.43 Mn |
| Jun 30, 2022 | 160.11 Mn |
| Mar 31, 2022 | 124.38 Mn |
| Dec 31, 2021 | 162.56 Mn |
| Sep 30, 2021 | 157.99 Mn |